Globus Medical Adds Two Innovative Solutions to Growing Trauma Portfolio
July 03 2018 - 7:30AM
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal
solutions company, announced today the expansion of its orthopedic
trauma product portfolio with two new product offerings, the
ANTHEM® Ankle Fracture System and the ANTHEM® Proximal Humerus
Fracture System, marking the Trauma division’s fourth and fifth
comprehensive product launches over the last 10 months.
“This is an exciting time for Globus Trauma as we continue to
execute our product launch strategy and build a comprehensive
Trauma product portfolio,” said Barclay Davis, Vice President,
Orthopedic Trauma. “With each new product introduction, our goal is
to design systems that help streamline the procedure, increase
versatility, reduce operative time, and improve patient
care.”
ANTHEM® Ankle Fracture Plating and other lower extremity systems
will be exhibited at the annual American Orthopedic Foot and Ankle
Society Meeting in Boston, Massachusetts July 11th-14th.
Globus Medical invites meeting attendees to Booth 206 to experience
its recent product innovations and discuss trauma advancements with
the company’s product development experts.
- The ANTHEM® Ankle Fracture System is an extensive range of 7
unique plating options for treatment of virtually any ankle
fracture. Over 25% thinner than the market leader’s plate,
ANTHEM®’s low profile ankle fracture plates are designed to
minimize soft tissue irritation from implant prominence.
Anatomically contoured plates, extensive screw options and
instruments specifically designed for ankle anatomy are rolled into
one efficient and comprehensive system for treating ankle
fractures.
- The ANTHEM® Proximal Humerus Fracture System is designed to
treat a wide variety of shoulder fractures and streamline
procedural flow. The unique polyaxial screw technology allows for
more accurate targeting of dense calcar bone to enhance fixation,
independent of plate position. Large suture holes simplify suture
attachment for soft tissue or rotator cuff repair. This
comprehensive stand-alone system includes small fragment
instruments and innovative retractors to help streamline the
surgical procedure, aid in visibility of the fracture site, and
optimize surgical time.
Indications
The ANTHEM™ Fracture System is indicated for
fixation of fractures, osteotomies, arthrodesis and reconstruction
of bones for the appropriate size of the device to be used in adult
patients, including the clavicle, scapula, humerus, radius, ulna,
small bones (metacarpals, metatarsals, phalanges), wrist, pelvis,
femur, tibia, fibula, ankle, and foot. The clavicle hook plate may
be used for dislocations of the acromioclavicular joint.
Small fragment, proximal tibia, clavicle and
distal fibula plates may be used in all pediatric subgroups (except
neonates) and small stature adults. Distal radius plates may
be used in adolescents (12-21 years of age). Plating may be used in
patients with osteopenic bone.
To learn more about the complete line of Globus Medical Trauma
products visit www.globusmedical.com/trauma.
About Globus Medical, Inc.Globus Medical, Inc.
is a leading musculoskeletal solutions company based in Audubon,
PA. The company was founded in 2003 by an experienced team of
professionals with a shared vision to create products that enable
surgeons to promote healing in patients with musculoskeletal
disorders. Additional information can be accessed
at http://www.globusmedical.com.
Safe Harbor StatementsAll statements included
in this press release other than statements of historical fact are
forward-looking statements and may be identified by their use of
words such as “believe,” “may,” “might,” “could,” “will,” “aim,”
“estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan”
and other similar terms. These forward-looking statements are based
on our current assumptions, expectations and estimates of future
events and trends. Forward-looking statements are only predictions
and are subject to many risks, uncertainties and other factors that
may affect our businesses and operations and could cause actual
results to differ materially from those predicted. These risks and
uncertainties include, but are not limited to, factors affecting
our quarterly results, our ability to manage our growth, our
ability to sustain our profitability, demand for our products, our
ability to compete successfully (including without limitation our
ability to convince surgeons to use our products and our ability to
attract and retain sales and other personnel), our ability to
rapidly develop and introduce new products, our ability to develop
and execute on successful business strategies, our ability to
comply with changing laws and regulations that are applicable to
our businesses, our ability to safeguard our intellectual property,
our success in defending legal proceedings brought against us,
trends in the medical device industry, general economic conditions,
and other risks. For a discussion of these and other risks,
uncertainties and other factors that could affect our results, you
should refer to the disclosure contained in our most recent annual
report on Form 10-K filed with the Securities and Exchange
Commission, including the sections labeled “Risk Factors” and
“Cautionary Note Concerning Forward-Looking Statements,” and in our
Forms 10-Q, Forms 8-K and other filings with the Securities and
Exchange Commission. These documents are available at www.sec.gov.
Moreover, we operate in an evolving environment. New risk factors
and uncertainties emerge from time to time and it is not possible
for us to predict all risk factors and uncertainties, nor can we
assess the impact of all factors on its business or the extent to
which any factor, or combination of factors, may cause actual
results to differ materially from those contained in any
forward-looking statements. Given these risks and uncertainties,
readers are cautioned not to place undue reliance on any
forward-looking statements. Forward-looking statements contained in
this press release speak only as of the date of this press release.
We undertake no obligation to update any forward-looking statements
as a result of new information, events or circumstances or other
factors arising or coming to our attention after the date
hereof.
Contact:Brian KearnsVice President, Business
Development and Investor RelationsPhone: (610) 930-1800Email:
investors@globusmedical.comwww.globusmedical.com
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Apr 2024 to May 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
From May 2023 to May 2024